All SPX-001 articles
-
NewsAstraZeneca seals obesity deal as Pfizer-Novo Nordisk battle for Metsera
After Wegovy and Zepbound's success, competition for the next potential weight loss blockbuster heats up.
After Wegovy and Zepbound's success, competition for the next potential weight loss blockbuster heats up.